Herborium Group Establishing a Strong foothold in $7 Billion Rapidly Growing French Beauty Market French Sales Grows Over 200% Since January 2014
Fort Lee, N.J. October 30, 2014 Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique, all botanical medicines (Botanical Therapeutics®) announced today that AcnEase® their proprietary all botanical acne treatment has established a strong foothold in the $7 Billion beauty market in France with a 200% increase in country sales since January 2014.
In response to this rapidly growing demand Herborium launched today a wholly designated country website www.acnease.fr. In addition, before the end of 2014 AcnEase will be sold in France by two leading retailers: Parashop, the leader in “parapharmacie” on the French market with 69 stores in France and 4 in Italy. Parashop had sales in 2013 of over 125 million Euros. Mondebio.com, a top French online retailer with a focus on the natural and/or organic beauty products will also begin to distribute AcnEase his year. Mondebio.com has been listed as one of the top French growing e-commerce businesses with annual sales growth of over 10%.
AcnEase® Social Media Strategy in France has been very successful and AcnEase is featured by top bloggers and YouTube personalities with over 3 million followers. AcnEase supporters in France include among others: Coline (et pourqois Coline), EnjoyPhoenix, one of the biggest Youtuber in France featured on French TV and in the legendary Elle Magazine and Sweet Honey Bee: a leading blogger focusing on young women with acne.
Frances population is 64.6 million, not including overseas territories, which makes it the 2nd most populated country in the European Union. More than 23% of the population in France has acne for a total of 15 million people. Acne affects about 80% of teens (15% with severe acne), nearly 20% of women and 13.8% of men aged from 35 to 54.
The French market is the 4th largest beauty market in the world (After United States, Japan and Brazil) and worth over $7 billion. Skin care is the main beauty expense in France with 32% of the market; it is also the fastest growing sector.
The natural cosmetics market has increased by approximately 20% every year since 2005 and should continue to grow, reaching €500 million in 2015.
Botanical Therapeutics such as AcnEase® is a perfect match for the French market. Herborium expects to continue its rapid growth in France especially since 86% of French consumers believe that there is a close link between beauty and wellness and they are also the world’s leading spenders on skincare products.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women’s health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.